Group One Trading
KYNB

Group One Trading’s Kyntra Bio KYNB Stock Holding History

Group One Trading’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.78K Hold
1,000
– – ﹤0.01% 6569
2025
Q4 		$8.78K Sell
1,000
-1,000
-50% -$9.77K ﹤0.01% 6881
2025
Q3 		$24.5K Sell
2,000
-200
-9% -$1.88K ﹤0.01% 6545
2025
Q2 		$11.7K Buy
2,200
+2,116
+2,519% +$15.4K ﹤0.01% 6621
2025
Q1 		$651 Sell
84
-152
-64% -$1.82K ﹤0.01% 7245
2024
Q4 		$3.12K Sell
236
-8
-3% -$74 ﹤0.01% 6598
2024
Q3 		$2.43K Sell
244
-460
-65% -$6.94K ﹤0.01% 6098
2024
Q2 		$15.7K Buy
704
+284
+68% +$8.78K ﹤0.01% 5383
2024
Q1 		$24.7K Buy
+420
New +$18.1K ﹤0.01% 5272
2023
Q4 		– Sell
-96
Closed -$2.07K – 7616
2023
Q3 		$2.07K Sell
96
-20,092
-100% -$789K ﹤0.01% 7027
2023
Q2 		$1.36M Buy
20,188
+19,244
+2,039% +$7.96M ﹤0.01% 2061
2023
Q1 		$440K Sell
944
-1,476
-61% -$781K ﹤0.01% 2897
2022
Q4 		$969K Buy
2,420
+752
+45% +$288K ﹤0.01% 2438
2022
Q3 		$543K Buy
1,668
+824
+98% +$265K ﹤0.01% 3149
2022
Q2 		$223K Sell
844
-832
-50% -$213K ﹤0.01% 4186
2022
Q1 		$504K Sell
1,676
-576
-26% -$201K ﹤0.01% 3802
2021
Q4 		$794K Sell
2,252
-3,900
-63% -$1.21M ﹤0.01% 3593
2021
Q3 		$1.57M Buy
6,152
+632
+11% +$224K ﹤0.01% 2903
2021
Q2 		$3.67M Buy
5,520
+1,172
+27% +$675K ﹤0.01% 2001
2021
Q1 		$3.77M Buy
4,348
+1,360
+46% +$1.45M 0.01% 1806
2020
Q4 		$2.77M Buy
2,988
+1,496
+100% +$1.57M ﹤0.01% 1776
2020
Q3 		$1.53M Sell
1,492
-2,676
-64% -$2.88M ﹤0.01% 1820
2020
Q2 		$4.22M Sell
4,168
-1,064
-20% -$988K 0.02% 923
2020
Q1 		$4.54M Sell
5,232
-6,312
-55% -$6.27M 0.04% 578
2019
Q4 		$12.4M Buy
11,544
+3,804
+49% +$3.88M 0.08% 276
2019
Q3 		$7.16M Sell
7,740
-856
-10% -$940K 0.06% 406
2019
Q2 		$9.71M Sell
8,596
-2,836
-25% -$3.1M 0.09% 240
2019
Q1 		$15.5M Buy
11,432
+6,332
+124% +$8.59M 0.17% 105
2018
Q4 		$5.9M Buy
5,100
+4,072
+396% +$4.58M 0.05% 441
2018
Q3 		$1.56M Sell
1,028
-124
-11% -$191K 0.01% 1341
2018
Q2 		$1.8M Buy
1,152
+68
+6% +$88.6K 0.02% 1217
2018
Q1 		$1.25M Buy
1,084
+140
+15% +$184K 0.01% 1337
2017
Q4 		$1.12M Sell
944
-1,628
-63% -$2.04M 0.01% 1609
2017
Q3 		$3.46M Sell
2,572
-1,148
-31% -$1.21M 0.03% 707
2017
Q2 		$3M Buy
3,720
+1,388
+60% +$967K 0.03% 715
2017
Q1 		$1.44M Buy
+2,332
New +$1.42M 0.02% 1076
2016
Q4 		– Sell
-288
Closed -$149K – 4528
2016
Q3 		$149K Sell
288
-328
-53% -$155K ﹤0.01% 2674
2016
Q2 		$253K Sell
616
-124
-17% -$56.8K ﹤0.01% 2242
2016
Q1 		$394K Buy
740
+540
+270% +$269K 0.01% 1846
2015
Q4 		$152K Sell
200
-480
-71% -$319K ﹤0.01% 2689
2015
Q3 		$373K Buy
680
+36
+6% +$21.8K 0.01% 2012
2015
Q2 		$378K Buy
+644
New +$375K 0.01% 2017

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Group One Trading's KYNB Position: Q1 2026 in Review

Group One Trading reduced its Kyntra Bio (KYNB) stake by 2.1% in Q1 2026, selling an estimated $751 and leaving 4,492 shares worth $30.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5659.

Group One Trading first reported a position in KYNB in Q2 2015 and has held it in 38 quarters since. The position peaked at $5.88M in Q1 2019. 32 funds tracked by Wall St. Rank hold KYNB as of Q1 2026.

  • Group One Trading held 4,492 shares of Kyntra Bio worth $30.5K as of Q1 2026.
  • Group One Trading sold 96 Kyntra Bio shares in Q1 2026, an estimated $751.
  • Kyntra Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5659 holding.
  • Group One Trading first reported a position in Kyntra Bio in Q2 2015 and has held it in 38 quarters since.
  • Group One Trading's Kyntra Bio position peaked at $5.88M in Q1 2019.
  • 32 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.